Execution Risk In MonetizationPlanned monetization of the medical device business to eliminate related debt depends on successful divestiture execution, creating execution risk that could constrain balance-sheet simplification.
Near-term Profitability RiskInclusion of the acquired medical device business raises projected operating losses, creating pressure on near-term profitability until integration or monetization reduces costs.
Regulatory And Asset-sale UncertaintyAnalyst makes no assumptions about future regulatory approvals or asset sales for the medical business, implying uncertain timing and outcomes that could delay expected benefits.